7Baggers

Phibro Animal Health Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 088.98177.97266.95355.93444.91533.9622.88Milllion

Phibro Animal Health Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2006-03-31 2005-09-30 2005-06-30 
                                                 
  ​                                               
  assets                                               
  cash and cash equivalents68,039,000 60,354,000 67,074,000 51,837,000 70,613,000 50,225,000 32,970,000 43,153,000 41,281,000 37,238,000 68,422,000 76,280,000 74,248,000 70,748,000 63,385,000 41,175,000 50,212,000 49,103,000 34,534,000 30,969,000 36,343,000 26,748,000 26,180,000 54,893,000 57,573,000 35,876,000 31,336,000 25,860,000 29,168,000 30,553,000 40,185,000   49,310,000 39,220,000 37,415,000         9,752,000 10,154,000 13,001,000 
  short-term investments9,000,000 10,000,000  38,000,000 44,000,000 48,523,000 59,523,000 48,000,000 40,000,000 40,000,000 10,000,000 10,000,000 17,000,000 22,100,000 32,100,000 56,000,000 43,000,000 44,000,000 61,000,000 61,000,000 55,000,000 55,000,000 49,000,000 24,000,000 24,000,000 49,000,000 49,000,000 50,000,000 50,000,000 45,000,000 27,000,000                 
  accounts receivable227,983,000 197,518,000 191,789,000 160,777,000 169,452,000 161,087,000 150,627,000 149,228,000 163,479,000 152,740,000 151,830,000 142,728,000 166,537,000 156,561,000 142,495,000 140,644,000 146,852,000 135,562,000 126,026,000 125,457,000 126,522,000 151,556,000 147,441,000 145,444,000 159,022,000 152,968,000 144,050,000 134,815,000 135,742,000 127,044,000 132,242,000   113,130,000 124,131,000 119,607,000         60,009,000   
  inventories444,425,000 448,390,000 427,224,000 272,556,000 265,911,000 282,289,000 286,680,000 279,154,000 277,570,000 292,833,000 288,984,000 280,842,000 259,158,000 249,911,000 230,784,000 221,313,000 216,312,000 206,258,000 213,331,000 205,846,000 196,659,000 177,287,000 193,509,000 203,873,000 198,322,000 189,878,000 193,099,000 185,794,000 178,170,000 184,478,000 173,613,000   163,831,000 158,819,000 162,644,000         93,911,000 99,261,000 96,621,000 
  other current assets61,159,000 59,756,000 60,066,000 47,597,000 51,021,000 55,056,000 56,786,000 64,889,000 63,393,000 62,672,000 62,453,000 60,230,000 49,289,000 47,157,000 39,846,000 39,498,000 42,533,000 36,795,000 42,276,000 41,010,000 37,313,000 27,564,000 29,357,000 27,302,000 27,245,000 24,002,000 23,605,000 23,324,000 22,381,000 20,351,000 23,407,000   21,273,000 16,839,000 20,102,000            
  total current assets810,606,000 776,018,000 746,153,000 570,767,000 600,997,000 597,180,000 586,586,000 584,424,000 585,723,000 585,483,000 581,689,000 570,080,000 566,232,000 546,477,000 508,610,000 498,630,000 498,909,000 471,718,000 477,167,000 464,282,000 451,837,000 438,155,000 445,487,000 455,512,000 466,162,000 451,724,000 441,090,000 419,793,000 415,461,000 407,426,000 396,447,000   347,544,000 339,009,000 339,768,000            
  property, plant and equipment354,690,000 336,093,000 337,662,000 206,315,000 203,300,000 202,061,000 200,839,000 193,359,000 195,568,000 188,939,000 186,122,000 179,393,000 165,490,000 162,455,000 154,584,000 152,830,000 154,706,000 150,188,000 150,337,000 147,256,000 148,109,000 143,112,000 144,733,000 142,164,000 140,235,000 134,654,000 132,711,000 130,786,000 130,108,000 126,680,000 127,940,000   127,235,000 127,180,000 127,336,000         48,972,000 48,709,000 49,960,000 
  intangibles36,469,000 37,766,000 39,894,000 42,935,000 45,033,000 48,239,000 50,962,000 52,184,000 54,987,000 56,901,000 59,064,000 61,133,000 63,861,000 67,384,000 57,971,000 60,125,000 62,282,000 64,434,000 66,630,000 68,792,000 70,997,000 73,208,000 75,541,000 77,536,000 47,478,000 48,970,000 50,509,000 51,888,000 51,978,000 54,388,000 56,454,000   58,447,000 57,134,000 58,572,000         9,096,000 9,829,000 10,201,000 
  goodwill59,645,000 54,570,000 54,549,000 54,588,000 54,557,000 54,644,000 54,683,000 53,251,000 53,274,000 53,243,000 53,228,000 53,209,000 53,226,000 53,321,000 52,679,000 52,679,000 52,679,000 52,679,000 52,679,000 52,679,000 52,679,000 52,679,000 52,679,000 52,990,000 27,348,000 27,348,000 27,348,000 27,348,000 27,348,000 29,624,000 29,624,000   21,121,000 21,121,000 21,121,000            
  other assets99,490,000 112,813,000 107,251,000 91,684,000 78,297,000 76,911,000 79,638,000 81,305,000 81,845,000 80,866,000 81,730,000 84,563,000 82,890,000 86,544,000 75,114,000 71,780,000 72,749,000 65,998,000 56,838,000 56,545,000 60,478,000 68,896,000 69,878,000 67,037,000 45,448,000 43,724,000 45,634,000 48,660,000 46,784,000 52,726,000 52,665,000   47,931,000 47,841,000 51,287,000         11,234,000 12,886,000 14,070,000 
  total assets1,360,900,000 1,317,260,000 1,285,509,000 966,289,000 982,184,000 979,035,000 972,708,000 964,523,000 971,397,000 965,432,000 961,833,000 948,378,000 931,699,000 916,181,000 848,958,000 836,044,000 841,325,000 805,017,000 803,651,000 789,554,000 784,100,000 776,050,000 788,318,000 795,239,000 726,671,000 706,420,000 697,292,000 678,475,000 671,679,000 670,844,000 663,130,000   602,278,000 592,285,000 598,084,000            
  liabilities and stockholders' equity                                               
  current portion of long-term debt16,250,000 16,250,000 16,250,000 7,500,000 29,795,000  26,045,000 24,150,000 22,295,000 15,420,000 15,420,000 15,420,000 15,000,000 15,000,000 13,125,000 11,250,000 9,375,000 23,437,000 21,875,000 20,312,000 18,750,000 17,188,000 15,625,000 14,084,000 12,540,000 12,560,000 12,577,000 12,580,000 12,579,000 11,020,000 9,458,000   2,900,000 2,901,000 2,903,000         223,000 1,000,000 1,625,000 
  accounts payable138,201,000 131,622,000 99,445,000 86,528,000 85,567,000 82,613,000 86,410,000 77,216,000 73,853,000 75,768,000 80,487,000 88,379,000 95,596,000 89,696,000 80,663,000 66,805,000 68,362,000 62,803,000 63,306,000 62,497,000 66,091,000 68,162,000 58,263,000 61,372,000 73,189,000 64,289,000 65,095,000 61,870,000 59,498,000 64,127,000 64,779,000   53,271,000 54,826,000 54,274,000         38,781,000 32,506,000 36,347,000 
  accrued expenses and other current liabilities139,022,000 118,609,000 117,555,000 82,866,000 88,786,000 76,648,000 75,280,000 70,989,000 79,852,000 74,120,000 71,662,000 68,700,000 80,236,000 82,406,000 72,840,000 74,531,000 86,379,000 82,651,000 81,722,000 78,143,000 72,397,000 75,882,000 73,171,000 66,517,000 68,498,000 55,687,000 58,157,000 54,281,000 71,144,000 53,397,000 52,999,000   50,126,000 45,602,000 44,159,000         53,985,000 59,769,000 53,815,000 
  total current liabilities293,473,000 266,481,000 233,250,000 176,894,000 204,148,000 189,072,000 187,735,000 172,355,000 176,000,000 165,308,000 167,569,000 172,499,000 190,832,000 187,102,000 166,628,000 152,586,000 164,116,000 168,891,000 166,903,000 160,952,000 157,238,000 161,232,000 147,059,000 141,973,000 154,227,000 132,536,000 135,829,000 128,731,000 143,221,000 128,544,000 127,236,000   106,297,000 103,329,000 101,336,000            
  revolving credit facility87,000,000 92,000,000 114,000,000 179,000,000 176,000,000 165,000,000 151,000,000 154,000,000 141,000,000 193,000,000 184,000,000 171,000,000 145,000,000 124,000,000 107,000,000 110,000,000 95,000,000 176,000,000 178,000,000 185,000,000 169,000,000 146,000,000 149,000,000 168,000,000 96,000,000 96,000,000 88,000,000 85,000,000 70,000,000 65,500,000 71,000,000   30,000,000 48,500,000 62,000,000            
  long-term debt615,435,000 619,157,000 622,880,000 287,668,000 282,289,000 291,008,000 297,853,000 304,717,000 311,541,000 273,016,000 276,806,000 280,738,000 272,925,000 276,621,000 280,317,000 284,014,000 287,710,000 180,786,000 186,943,000 193,100,000 199,257,000 203,851,000 208,446,000 213,040,000 217,635,000 220,667,000 223,699,000 226,750,000 229,802,000 232,856,000 235,910,000   276,565,000 277,132,000 277,698,000         176,451,000 176,411,000 176,501,000 
  other liabilities79,310,000 73,630,000 68,577,000 64,200,000 63,106,000 63,861,000 65,317,000 60,382,000 60,347,000 61,780,000 65,088,000 61,385,000 60,500,000 61,513,000 55,719,000 56,139,000 55,970,000 63,419,000 58,483,000 58,090,000 70,401,000 69,622,000 66,398,000 65,532,000 42,794,000 43,498,000 44,540,000 45,937,000 43,702,000 58,399,000 60,659,000   50,005,000 50,711,000 54,774,000         23,231,000 20,058,000 21,465,000 
  total liabilities1,075,218,000 1,051,268,000 1,038,707,000 707,762,000 725,543,000 708,941,000 701,905,000 691,454,000 688,888,000 693,104,000 693,463,000 685,622,000 669,257,000 649,236,000 609,664,000 602,739,000 602,796,000 589,096,000 590,329,000 597,142,000 595,896,000 580,705,000 570,903,000 588,545,000 510,656,000 492,701,000 492,068,000 486,418,000 486,725,000 485,299,000 494,805,000   462,867,000 479,672,000 495,808,000            
  commitments and contingencies                                               
  common stock4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000 4,000   4,000 4,000 4,000         2,000 2,000  
  preferred stock, par value 0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding                                               
  paid-in capital136,995,000 136,816,000 136,637,000 136,457,000 136,278,000 136,099,000 135,964,000 135,884,000 135,803,000 135,803,000 135,803,000 135,803,000 135,803,000 135,803,000 135,803,000 135,803,000 135,803,000 136,654,000 136,654,000 136,090,000 135,525,000 134,960,000 134,395,000 133,831,000 133,266,000 132,701,000 131,343,000 130,649,000 129,873,000 129,132,000 127,540,000   120,879,000 118,409,000 118,299,000         27,260,000 27,260,000 27,260,000 
  retained earnings272,701,000 260,341,000 244,326,000 246,001,000 243,886,000 247,995,000 244,450,000 248,037,000 260,912,000 254,275,000 249,094,000 246,744,000 247,748,000 245,122,000 232,293,000 219,689,000 218,015,000 205,755,000 198,454,000 190,508,000 183,060,000 182,273,000 173,626,000 166,587,000 168,926,000 164,978,000 154,984,000 145,082,000 131,560,000 113,477,000 97,666,000   71,358,000 51,674,000 42,198,000            
  accumulated other comprehensive loss-124,018,000 -131,169,000 -134,165,000 -123,935,000 -123,527,000 -114,004,000 -109,615,000 -110,856,000 -114,210,000 -117,754,000 -116,531,000 -119,795,000 -121,113,000 -113,984,000 -128,806,000 -122,191,000 -115,293,000 -126,492,000                              
  total stockholders’ equity285,682,000 265,992,000 246,802,000 258,527,000 256,641,000 270,094,000 270,803,000 273,069,000 282,509,000 272,328,000 268,370,000 262,756,000 262,442,000 266,945,000 239,294,000 233,305,000 238,529,000 215,921,000 213,322,000 192,412,000 188,204,000  217,415,000 206,694,000 216,015,000 213,719,000 205,224,000 192,057,000 184,954,000 185,545,000 168,325,000   139,411,000 112,613,000 102,276,000            
  total liabilities and stockholders’ equity1,360,900,000 1,317,260,000 1,285,509,000 966,289,000 982,184,000 979,035,000 972,708,000 964,523,000 971,397,000 965,432,000 961,833,000 948,378,000 931,699,000 916,181,000 848,958,000 836,044,000 841,325,000 805,017,000 803,651,000 789,554,000 784,100,000  788,318,000 795,239,000 726,671,000 706,420,000 697,292,000  671,679,000 670,844,000 663,130,000   602,278,000 592,285,000 598,084,000            
  liabilities and stockholders’ equity                                               
  current portion of long-term debt and other     29,811,000                                          
  accumulated other comprehensive                  -121,790,000                             
  accumulated other comprehensive income                   -134,190,000 -130,385,000 -121,892,000 -90,610,000 -93,728,000 -86,181,000 -83,964,000 -81,107,000 -83,678,000 -76,483,000 -57,068,000 -56,885,000   -52,830,000 -57,474,000 -58,225,000            
  preferred stock,        par value 0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding                                               
  total stockholders' equity                     195,345,000                          
  total liabilities and stockholders' equity                     776,050,000      678,475,000                    
  preferred stock, par value 0.0001; 16,000,000 shares authorized, no shares issued and outstanding                                               
  accumulated deficit                                            -80,544,000 -77,170,000 -74,379,000 
  prepaid expenses and other current assets                                            10,832,000 12,653,000 12,787,000 
  current assets                                               
  liabilities and stockholders’ deficit                                               
  current liabilities                                               
  loans payable to banks                                             4,325,000 8,038,000 
  stockholders’ deficit                                               
  preferred stock                                            521,000 521,000  
  net sales                                            100,905,000   
  cost of goods sold                                            76,442,000   
  gross profit                                            24,463,000   
  selling, general and administrative expenses                                            17,527,000   
  operating income                                            6,936,000   
  interest expense                                            6,726,000   
  interest                                            -53,000   
  other income                                            31,000   
  income from continuing operations before income taxes                                            232,000   
  benefit from income taxes                                            1,591,000   
  (loss) from continuing operations                                            -1,359,000   
  income from discontinued operations, net of income taxes                                               
  net                                            -1,359,000   
  other comprehensive income:                                               
  change in derivative instruments, net of income taxes                                            76,000   
  change in foreign currency translation adjustment, net of income taxes                                            2,482,000   
  comprehensive income                                            1,199,000   
  excess of the reduction of series b and c preferred stock over total assets divested and costs and liabilities incurred on the prince transactions                                               
  dividends and equity value adjustment on series c preferred stock                                               
  net (loss) attributable to common stockholders                                            -1,359,000   
  current assets:                                               
  other receivables                                             4,295,000 3,611,000 
  current liabilities:                                               
  cash overdraft                                             413,000 190,000 
  stockholders’ deficit:                                               
  accumulated other comprehensive income:                                               
  other:                                               
  discontinued operations:                                               
  dividends and equity value accreted on series c preferred stock                                               
  current assets from discontinued operations                                               
  other assets from discontinued operations                                               
  current liabilities from discontinued operations                                               
  redeemable securities:                                               
  series c preferred stock                                               
  costs of non-completed transaction                                               
  net (gain) on extinguishment of debt                                               
  income from continuing operations                                               
  income on disposal of discontinued operations, net of income taxes                                               
  net income                                               
  change in currency translation adjustment, net of income taxes                                               
  excess of the reduction of redeemable preferred stock over total assets divested and costs and liabilities incurred on the prince transactions                                               
  dividends and equity value accreted on series b and c redeemable preferred stock                                               
  net income available (loss attributable) to common shareholders                                               

We provide you with 20 years of balance sheets for Phibro Animal Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Phibro Animal Health. Explore the full financial landscape of Phibro Animal Health stock with our expertly curated balance sheets.

The information provided in this report about Phibro Animal Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.